Access cutting-edge ischemic heart disease treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access ischemic heart disease specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ischemic heart disease treatment provided free
This is a Phase IIA, randomized, double blind, placebo controlled, multicenter study designed to assess the safety, feasibility, and efficacy of umbilical cord derived mesenchymal stromal cells (UC MSCs), administered intravenously (IV) as a single dose or repeated doses, in patients with ischemic cardiomyopathy (ICM).
Sponsor: Roberto Bolli
Check if you qualify for this ischemic heart disease clinical trial in Houston, TX
If you're searching for ischemic heart disease treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ischemic heart disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.